Leadership Team

Trent Basarsky, PhD

VP, Corporate Development



Dr. Trent Basarsky is the Vice President of our Corporate Development. Trent is a marketing and business executive with more than 20 years of experience in the life sciences sector. Prior to joining 908 Devices, Trent was the Chief Business Officer at Zephyrus Biosciences, the developers of a single cell western platform, which was acquired by BioTechne in 2016. Previously Trent was the VP of Corporate Development at ProteinSimple, a company focused on protein analysis instrumentation, where his responsibilities in corporate development, marketing and intellectual property helped grow the company to over $55M in revenue prior to the successful sale of the company for $300M. Trent served as the Director of Corporate Development at Codexis, a cleantech company focused on next-generation biofuels and pharmaceutical manufacturing. Before joining Codexis, he was Director of Corporate Development at Molecular Devices and helped grow the business to more than $180M prior to the sale of the company for over $600M. He also held positions in marketing, product management, business development and intellectual property at Axon Instruments, which was acquired by Molecular Devices. Trent holds a Ph.D. in Neuroscience from Iowa State University, a B.Sc. in Zoology from the University of Alberta, and is a registered patent agent. He enjoys endurance mountain bike racing, playing competitive hockey, and golf.

email Subscribe to Our Newsletter Signup to receive new product updates, technical tips and more.